T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.33% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DX
2501
Dynex Capital
DX
$3.23B
| $363K | ﹤0.01% |
21,033
-2,167
| -9% | -$38.3K |
|
2502
Groupon
GRPN
$894M
| $362K | ﹤0.01% |
15,867
-100
| -0.6% | -$2.96K |
|
2503
Compass
COMP
$10.2B
| $361K | ﹤0.01% |
+27,194
| New | +$391K |
|
2504
Northern Oil and Gas
NOG
$2.61B
| $360K | ﹤0.01% |
16,803
+341
| +2% | +$5.96K |
|
|
PFC
2505
DELISTED
Premier Financial Corp. Common Stock
PFC
| $360K | ﹤0.01% |
11,315
-21
| -0.2% | -$606 |
|
|
EMKR
2506
DELISTED
Emcore Corp
EMKR
| $357K | ﹤0.01% |
4,772
+2,323
| +95% | +$186K |
|
2507
Andersons Inc
ANDE
$2.21B
| $355K | ﹤0.01% |
11,514
+104
| +0.9% | +$3K |
|
2508
Photronics
PLAB
$1.97B
| $354K | ﹤0.01% |
26,005
-224
| -0.9% | -$3.04K |
|
2509
Cenovus Energy
CVE
$56.4B
| $353K | ﹤0.01% |
35,024
| – | – |
|
2510
ACM Research
ACMR
$5.65B
| $352K | ﹤0.01% |
9,600
| – | – |
|
2511
Green Plains
GPRE
$1.09B
| $352K | ﹤0.01% |
10,786
-1,221
| -10% | -$41.9K |
|
2512
KALA BIO
KALA
$17.9M
| $352K | ﹤0.01% |
54
+31
| +135% | +$268K |
|
2513
Ingles Markets
IMKTA
$1.68B
| $349K | ﹤0.01% |
5,281
-39
| -0.7% | -$2.47K |
|
2514
Usana Health Sciences
USNA
$252M
| $349K | ﹤0.01% |
3,781
+20
| +0.5% | +$1.92K |
|
2515
Washington Trust Bancorp
WASH
$767M
| $348K | ﹤0.01% |
6,566
| – | – |
|
2516
Ocular Therapeutix
OCUL
$2.22B
| $346K | ﹤0.01% |
34,560
-100
| -0.3% | -$1.12K |
|
|
VBIV
2517
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $345K | ﹤0.01% |
3,702
+20
| +0.5% | +$1.9K |
|
|
CODX
2518
Co-Diagnostics
CODX
$5.49M
| $344K | ﹤0.01% |
1,180
-140
| -11% | -$40.9K |
|
2519
Hyster-Yale Materials Handling
HY
$617M
| $344K | ﹤0.01% |
6,847
+1,952
| +40% | +$120K |
|
|
OLP
2520
One Liberty Properties
OLP
$537M
| $343K | ﹤0.01% |
11,263
-35
| -0.3% | -$1.07K |
|
2521
Asure Software
ASUR
$251M
| $342K | ﹤0.01% |
37,980
| – | – |
|
|
VELOU
2522
DELISTED
Velocity Acquisition Corp. Units
VELOU
| $342K | ﹤0.01% |
33,986
+13,563
| +66% | +$137K |
|
2523
Ethan Allen Interiors
ETD
$583M
| $341K | ﹤0.01% |
14,391
| – | – |
|
2524
Barrett Business Services
BBSI
$800M
| $338K | ﹤0.01% |
17,740
-60
| -0.3% | -$1.12K |
|
|
SBEAU
2525
DELISTED
SilverBox Engaged Merger Corp I Units
SBEAU
| $338K | ﹤0.01% |
33,971
+13,563
| +66% | +$135K |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.